28540-full
lynzee
Data Quality: 1 star
  • Sex: F
  • Age: 21y
  • Duration: 6 yrs
PRO survey: PRO 0
Quality of Life:
  • Mental: Unreported
  • Physical: Unreported
0 seizures
120 weeks ago
lynzee
Female, 21 years
Murrieta , CA
Primary Condition
Epilepsy and 2 more
First seizure
?
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

lynzee's Zoloft is for:

  • Panic Disorder/ aggravated by epilepsy
  • GAD
  • PTSD

lynzee's side effects of Zoloft:

lynzee's Zoloft History (Ongoing)
Zoloft (sertraline)
20 mg Daily Jan 23 - Apr 07, 2010
50 mg Daily Apr 07, 2010 - Last Update
Evaluations
Date Dosage Panic Disorder/ aggravated by epilepsy Perceived effectiveness Generalized Anxiety Disorder Perceived effectiveness PTSD (Post Traumatic Stress Disorder) Perceived effectiveness Side Effects Adherence Burden
Oct 08, 2010 50 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 MildMildMildMild AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
Oct 08, 2010
Advice & Tips
I started Zoloft originally in January 23, 2007, however since it worked so well, I went off of it in March 2009. This was the biggest mistake of my life. My anxiety went from being almost gone to worse than i was actually diagnosed. As a result I ended up in the hospital's psych ward, and eventually a year later a doctor finally prescribed me zoloft again, and i began taking it again. I've had no complaints since besides minor insomnia.
Cost
< $25 monthly

About Zoloft (Prescription Drug)

Zoloft is a brand name for sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant. It is used in the treatment of major depression; obsessive-compulsive disorder; panic disorder; post-traumatic stress disorder; premenstrual dysphoric disorder; and social anxiety disorder.

Learn more about Zoloft in our Zoloft Community Report.